Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001708138-21-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-10 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $666.42 | -781 | 30.7K | -2% | -$520.5K |
| D | 2021-12-10 | 2021-12-08 | REGN | Landry Robert E | EVP Fin CFO | A - Grant | $0.00 | +3,971 | 30.0K | +15% | $0 |
| D | 2021-12-10 | 2021-12-09 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $399.66 | +4,250 | 34.2K | +14% | +$1.70M |
| D | 2021-12-10 | 2021-12-09 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $657.11 | -3,469 | 30.7K | -10% | -$2.28M |
| D | 2021-12-10 | 2021-12-09 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $0.00 | -4,250 | 17.0K | -20% | $0 |
| D | 2021-12-10 | 2021-12-08 | REGN | Landry Robert E | EVP Fin CFO | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | S | D | 7 | $667.80 | 30,396 | D | — | — | (F10) Represents volume-weighted average price of sales of 7 shares of Company stock on December 10, 2021 at prices ranging from $667.39 to $667.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-12-10 | S | D | 25 | $661.48 | 30,646 | D | — | — | (F6) Represents volume-weighted average price of sales of 25 shares of Company stock on December 10, 2021 at prices ranging from $661.26 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-12-10 | S | D | 130 | $669.48 | 30,088 | D | — | — | (F12) Represents volume-weighted average price of sales of 130 shares of Company stock on December 10, 2021 at prices ranging from $669.43 to $669.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-12-10 | S | D | 58 | $670.13 | 30,030 | D | — | — | (F13) Represents volume-weighted average price of sales of 58 shares of Company stock on December 10, 2021 at prices ranging from $670.12 to $670.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-12-10 | S | D | 14 | $671.42 | 30,016 | D | — | — | (F14) Represents volume-weighted average price of sales of 14 shares of Company stock on December 10, 2021 at prices ranging from $671.42 to $671.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-12-10 | S | D | 59 | $672.30 | 29,957 | D | — | — | |
| 7 | Common | Common Stock | 2021-12-10 | S | D | 123 | $662.06 | 30,523 | D | — | — | (F7) Represents volume-weighted average price of sales of 123 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-12-10 | S | D | 19 | $663.41 | 30,504 | D | — | — | (F8) Represents volume-weighted average price of sales of 19 shares of Company stock on December 10, 2021 at prices ranging from $663.16 to $663.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-12-10 | S | D | 15 | $664.71 | 30,489 | D | — | — | |
| 10 | Common | Common Stock | 2021-12-10 | S | D | 18 | $665.44 | 30,471 | D | — | — | (F9) Represents volume-weighted average price of sales of 18 shares of Company stock on December 10, 2021 at prices ranging from $665.20 to $665.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-12-10 | S | D | 68 | $666.19 | 30,403 | D | — | — | |
| 12 | Common | Common Stock | 2021-12-10 | S | D | 178 | $668.21 | 30,218 | D | — | — | (F11) Represents volume-weighted average price of sales of 178 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 13 | Common | Common Stock | 2021-12-08 | A | A | 3,971 | $0.00 | 29,957 | D | — | — | |
| 14 | Common | Common Stock | 2021-12-09 | M | A | 4,250 | $399.66 | 34,207 | D | — | — | |
| 15 | Common | Common Stock | 2021-12-09 | F | D | 3,469 | $657.11 | 30,738 | D | — | — | |
| 16 | Common | Common Stock | 2021-12-10 | S | D | 2 | $656.46 | 30,736 | D | — | — | |
| 17 | Common | Common Stock | 2021-12-10 | S | D | 50 | $657.53 | 30,686 | D | — | — | (F3) Represents volume-weighted average price of sales of 50 shares of Company stock on December 10, 2021 at prices ranging from $657.19 to $657.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 18 | Common | Common Stock | 2021-12-10 | S | D | 11 | $658.52 | 30,675 | D | — | — | (F4) Represents volume-weighted average price of sales of 11 shares of Company stock on December 10, 2021 at prices ranging from $658.10 to $658.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 19 | Common | Common Stock | 2021-12-10 | S | D | 4 | $659.49 | 30,671 | D | — | — | (F5) Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $659.36 to $659.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. |
| 20 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-12-09 | M | D | 4,250 | $0.00 | 17,000 | D | $399.66 · — to 2024-12-16 | 4,250 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 21 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-12-08 | A | A | 16,958 | $0.00 | 16,958 | D | $644.54 · — to 2031-12-08 | 16,958 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |